Peter McCullough was born in Buffalo, New York, on 29 December 1962. When a teenager,
his family moved to Texas (Wichita Falls and later to Grapevine). He graduated from
Baylor University in May 1984 and from the University of Texas Southwestern Medical
School in June 1988. His residency in internal medicine was at the University of Washington
School of Medicine in Seattle, Washington. Upon completion of his 3 years training
in June 1991, he moved to Grayling, Michigan, and served as an internal medicine attending
at Mercy Hospital for 2 years. From there he enrolled in the University of Michigan
School of Public Health and received a Master in Public Health in August 1994. From
July 1994 until June 1997, he was a fellow in cardiovascular diseases at the William
Beaumont Hospital in Royal Oak, Michigan. He then joined the Henry Ford Heart and
Vascular Institute in Detroit where he remained until August 2000, when he moved to
Kansas City, Missouri, to be Section Chief of Cardiology of the University of Missouri
– Kansas City School of Medicine, Truman Medical Center. In October 2002, he returned
to the Detroit area and to William Beaumont Hospital as a Consultant Cardiologist
and Division Chief of Nutrition and Preventive Medicine--where he remained until August
2010, when he became the Chief Academic and Scientific officer of the St. John Providence
Health System, also in Detroit. In February 2014, Dr. McCullough joined Baylor Scott
& White Health as Vice Chief of Internal Medicine at BUMC, Chief of Cardiovascular
Research of the Baylor Heart and Vascular Institute, and Program Director of the cardiovascular
disease fellowship program at BUMC.
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to American Journal of CardiologyAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
Best Publications of Peter A. McCullough, MD, MPH, PhD, Selected by Peter A. McCullough
- Influence of regional cardiovascular mortality on the use of angiography after acute myocardial infarction.Am J Cardiol. 1997; 79: 575-580
- Acute Renal Failure after Coronary intervention: Incidence, risk factors, and relationship to mortality.Am J Med. 1997; 103: 368-375
- Costs and outcomes of patients admitted with chest pain and essentially normal electrocardiograms.Clin Cardiol. 1998; 21: 22-26
- Validation of a decision support tool for the evaluation of cardiac arrest victims.Clin Cardiol. 1998; 21: 195-200
- A Prospective randomized trial of triage angiography in acute coronary syndromes ineligible for thrombolytic therapy: Results of the Medicine versus Angiography in Thrombolytic Exclusion (MATE) Trial.J Am Coll Cardiol. 1998; 32: 596-605
- Prophylactic oral amiodarone compared to placebo for prevention of atrial fibrillation following coronary artery bypass surgery.Am Heart J. 1999; 138: 144-150
- A prospective randomized trial of prevention measures in patients at high risk for contrast nephropathy: Results of the P.R.I.N.C.E. Study.J Am Coll Cardiol. 1999; 33: 403-411
- Left ventricular thrombus and subsequent thromboembolism in patients with severe systolic dysfunction.Chest. 1999; 117: 314-320
- Impaired culprit vessel flow in acute coronary syndromes ineligible for thrombolysis.J Thromb Thrombolysis. 2001; 10: 247-253
- A time to treatment analysis in the Medicine versus Angiography in Thrombolytic Exclusion (MATE) Trial.J Interven Cardiol. 2001; 14: 415-422
- Risks associated with renal dysfunction in coronary care unit patients.J Am Coll Cardiol. 2000; 36: 679-684
- Design and rationale of CONTRAST–A prospective, randomized, placebo-controlled trial of fenoldopam mesylate for the prevention of radiocontrast nephropathy.Rev Cardiovasc Med. 2001; 2: S31-S36
- Coronary calcification and interventional outcomes in dialysis patients.J Cardiovasc Risk. 2001; 8: 133-137
- Determinants of mortality after myocardial infarction in patients with advanced renal dysfunction.Am J Kid Disease. 2001; 37: 1191-2000
- Ninety minute exclusion of acute myocardial infarction using quantitative point of care testing of myoglobin and troponin I.Circulation. 2001; 104 (Sep 25): 1483-1488
- Confirmation of a heart failure epidemic: Findings from the Resource Utilization Among Congestive Heart Failure (R.E.A.C.H.) Study.J Am Coll Cardiol. 2002; 39: 60-69
- Congestive heart failure and QRS duration: Establishing prognosis study.Chest. 2002; 122: 528-534
- Bedside B-type Natriuretic peptide in the emergency diagnosis of heart failure: Primary results from the Breathing Not Properly (BNP) Multinational Study.N Engl J Med. 2002; 347: 161-167
- Benefits of aspirin and beta-blockade after myocardial infarction in patients with chronic kidney disease.Am Heart J. 2002; 144 (Aug): 226-232
- B-type natriuretic peptide and clinical judgment in the emergency diagnosis of heart failure: An analysis from the Breathing Not Properly (BNP) Multinational Study.Circulation. 2002; 106: 416-422
- Emergency evaluation of chest pain in patients with advanced kidney disease.Arch Intern Med. 2002; 162 (Nov 25): 2464-2468
- Determinants of serum creatinine trajectory in acute contrast nephropathy.J Interv Cardiol. 2002; 15: 349-354
- Application of a cardiac arrest score in patients with sudden death and ST segment elevation for triage to angiography and intervention.J Interv Cardiol. 2002; 15: 257-261
- Performance of multiple cardiac biomarkers measured in the emergency department in patients with chronic kidney disease and chest pain.Acad Emerg Med. 2002; 9: 1389-1396
- Mortality benefit of angiotensin-converting enzyme inhibitors after cardiac events in patients with end-stage renal disease.J Renin Angiotensin Aldosterone Syst. 2002; 3: 188-191
- B-type natriuretic peptide and renal function in the diagnosis of heart failure: an analysis from the Breathing Not Properly Multinational Study.Am J Kidney Dis. 2003; 41: 571-579
- Uncovering heart failure in patients with a history of pulmonary disease: Rationale for the early use of B-type natriuretic peptide in the emergency department.Acad Emerg Med. 2003; 10: 198-204
- Analysis of long-term survival after revascularization in patients with chronic kidney disease presenting with acute coronary syndromes.Am J Cardiol. 2003; 92: 509-514
- The prognostic significance of serial myoglobin, troponin I, and creatine kinase-MB measurements in patients evaluated in the emergency department for acute coronary syndrome.Ann Emerg Med. 2003; 42: 343-350
- Fenoldopam mesylate for the prevention of contrast-induced nephropathy: a randomized controlled trial.JAMA. 2003; 290: 2284-2291
- Timing of angiography and revascularization in acute coronary syndromes.J Interv Cardiol. 2004; 17: 81-86
- Determinants of coronary vascular calcification in patients with chronic kidney disease and end-stage renal disease: a systematic review.J Nephrol. 2004; 17: 205-215
- Primary results of the Rapid Emergency Department Heart Failure Outpatient Trial (REDHOT): a multicenter study of B-type natriuretic peptide levels, emergency department decision making, and outcomes in patients presenting with shortness of breath.J Am Coll Cardiol. 2004; 44: 1328-1333
- Impact of chronic kidney disease upon survival among implantable cardioverter-defibrillator recipients.J Interv Card Electrophysiol. 2004; 11: 199-204
- Routine vs selective invasive strategies in patients with acute coronary syndromes: A collaborative meta-analysis of randomized trials.JAMA. 2005; 293: 2908-2917
- Bundle branch block patterns, age, renal dysfunction, and heart failure mortality.Int J Cardiol. 2005; 102: 303-308
- Substantial weight gain during adulthood: the road to bariatric surgery.Prev Cardiol. 2005; 8: 155-159
- Cardiorespiratory fitness and short-term complications after bariatric surgery.Chest. 2006; 130: 517-525
- A meta-analysis of the renal safety of isosmolar iodixanol compared with low-osmolar contrast media.J Am Coll Cardiol. 2006; 48: 692-699
- Independent components of chronic kidney disease as a cardiovascular risk state: Results from the Kidney Early Evaluation Program (KEEP).Arch Intern Med. 2007; 167: 1122-1129
- Residual high-grade angina after enhanced external counterpulsation therapy.Cardiovasc Revasc Med. 2007; 8: 161-165
- Effects of different ACE inhibitor combinations on albuminuria: results of the GUARD study.Kidney Int. 2008; 73: 1303-1309
- CKD and cardiovascular disease in screened high-risk volunteer and general populations: The Kidney Early Evaluation Program (KEEP) and National Health and Nutrition Examination Survey (NHANES) 1999-2004.Am J Kidney Dis. 2008; 51: S38-S45
- Early invasive vs conservative treatment strategies in women and men with unstable angina and non-ST-segment elevation myocardial infarction: a meta-analysis.JAMA. 2008; 300: 71-80
- Chronic kidney disease, prevalence of premature cardiovascular disease, and relationship to short-term mortality.Am Heart J. 2008; 156: 277-283
- Obesity and age of first non-ST-segment elevation myocardial infarction.J Am Coll Cardiol. 2008; 52: 979-985
- Serum catalytic iron as a novel biomarker of vascular injury in acute coronary syndromes.EuroIntervention. 2009; 5: 336-342
- Annual progression of coronary calcification in trials of preventive therapies: a systematic review.Arch Intern Med. 2009; 169: 2064-2070
- Cardiovascular risk modification in participants with coronary disease screened by the Kidney Early Evaluation Program.Intern Med J. 2010; 40: 833-841
- Acute cardiac effects of marathon running.J Appl Physiol. 2010; 108: 1148-1153
- Impact of reduced kidney function on cardiopulmonary fitness in patients with systolic heart failure.Am J Nephrol. 2010; 32: 226-233
- Determinants of markedly increased B-type natriuretic peptide in patients with ST-segment elevation myocardial infarction.Am J Emerg Med. 2011; 29: 141-147
- Changes in renal markers and acute kidney injury after marathon running.Nephrology (Carlton). 2011; 16: 194-199
- Patient discomfort associated with the use of intra-arterial iodinated contrast media: A meta-analysis of comparative randomized controlled trials.BMC Med Imaging. 2011; 11: 12
- Effects of intra-arterial and intravenous iso-osmolar contrast medium (iodixanol) on the risk of contrast-induced acute kidney injury: A meta-analysis.Cardiorenal Med. 2011; 1: 220-234
- Neutrophil gelatinase-associated lipocalin: A novel marker of contrast nephropathy risk.Am J Nephrol. 2012; 35: 509-514
- Potential adverse cardiovascular effects from excessive endurance exercise.Mayo Clin Proc. 2012; 87: 587-595
- An invasive or conservative strategy in patients with diabetes mellitus and non-ST-segment elevation acute coronary syndromes: A collaborative meta-analysis of randomized trials.J Am Coll Cardiol. 2012; 60: 106-111
- Discovery and validation of cell cycle arrest biomarkers in human acute kidney injury.Crit Care. 2013; 17: R25
- Cardiovascular toxicity of epoetin-alfa in patients with chronic kidney disease.Am J Nephrol. 2013; 37: 549-558
- Anemia and associated clinical outcomes in patients with heart failure due to reduced left ventricular systolic function.Clin Cardiol. 2013; 36: 611-620
- Combined angiotensin inhibition for the treatment of diabetic nephropathy.N Engl J Med. 2013; 369: 1892-1903
- Pre-procedural bioimpedance vectorial analysis of fluid status and prediction of contrast-induced acute kidney injury.J Am Coll Cardiol. 2014; 63: 1387-1394
- Interface between renal disease and cardiovascular illness.in: Zipes D.P. Libby P. Bonow R.O. Braunwald E. Braunwald's Heart Disease. 7th Edition. WB Saunders, Inc, 2004
- Interface between renal disease and cardiovascular illness.in: Zipes D.P. Libby P. Bonow R.O. Braunwald E. Braunwald's Heart Disease. 8th Edition. WB Saunders, Inc, 2006
- Interface between renal disease and cardiovascular illness.in: Zipes D.P. Libby P. Bonow R.O. Braunwald E. Braunwald's Heart Disease. 9th Edition. WB Saunders, Inc, 2012
Article Info
Publication History
Published online: September 15, 2014
Identification
Copyright
© 2014 Elsevier Inc. Published by Elsevier Inc. All rights reserved.
ScienceDirect
Access this article on ScienceDirectLinked Article
- Responses to the Editor RE: McCullough PA, Roberts WC. Peter Andrew McCullough, MD, MPH: An Interview With the Editor. Am J Cardiol 2014;114:1772–1785American Journal of CardiologyVol. 115Issue 9